Advanced search×

Gastroentérologie Clinique et Biologique

Print ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Sciencedirect from 2004 to 2010

  1. Nicorandil: a curable cause of anal ulceration to be known...

    Gastroentérologie Clinique et Biologique 34(11):639 (2010) PMID 20884145

  2. [Collagenous gastritis and ileo-colitis occurred in autoimmune context: report of a case and review of the literature].

    Gastroentérologie Clinique et Biologique 34(8-9):e1 (2010) PMID 20637552

    We report the seventh case of collagenous gastritis, ileitis and colitis in a 75-year-old woman with chronic diarrhea and important weight loss. This thickened subepithelial collagen band was appeared in an autoimmune injury context with antecedent of Hashimoto's thyroiditis and probably chronic atr...
  3. Massive rectal bleeding distant from a blunt car trauma.

    Gastroentérologie Clinique et Biologique 34(8-9):499 (2010) PMID 20638207

    We report here a rare case of rectal bleeding by rupture of a mesosigmoid haematoma. An emergent laparotomy revealed a mesosigmoid haematoma with a centimetric rectal perforation. The wearing of safety belts added some specific blunt abdominal trauma, which directly depends on lap-and-sash belts. Me...
  4. Portal biliopathy.

    Gastroentérologie Clinique et Biologique 34(8-9):425 (2010) PMID 20692780

  5. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski meas...

    Gastroentérologie Clinique et Biologique 34(6-7):388 (2010) PMID 20580175

    ActiTest (AT) is a biomarker of liver necro-inflammatory histological activity validated in patients with chronic hepatitis C (HCV). The aim was to assess the accuracy of AT in comparison with alanine aminotransferase (ALT) the standard of care. Methods used an integrated database of individual data...
  6. Surgical management of liver metastases from gastrointestinal endocrine tumors.

    Gastroentérologie Clinique et Biologique 34(4-5):274 (2010) PMID 20347242

    Liver metastases from endocrine tumors can reduce 5-year survival from 90% to 40% and, in cases of functional gastrointestinal endocrine tumors, lead to a carcinoid syndrome. Complete resection of cancerous disease should be considered in all cases. Indeed, after hepatectomy, prolonged survival (41-...
  7. [Peripheric cholangiocarcinoma: radiopathologic correlations].

    Gastroentérologie Clinique et Biologique 34(3):181 (2010) PMID 20202773

  8. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.

    Gastroentérologie Clinique et Biologique 34(1):1 (2010) PMID 19762191

    Iron accumulation in the liver is considered to be a co-factor for progression of liver disease. Iron overload can enhance the effects of oxidative stress and influence the natural history of patients with cirrhosis, exposing them to a higher risk of hepatocellular carcinoma. The results of clinical...
  9. Genetic alterations in precancerous pancreatic lesions and their clinical implications.

    Gastroentérologie Clinique et Biologique 33(10-11):1028 (2009) PMID 19766418

    Pancreatic adenocarcinoma, with an incidence/death ratio of 0.99, has the worst prognosis of all cancers. Risk factors associated with the sporadic form of pancreatic adenocarcinoma are unknown and less than 10% of patients receive curative treatment (surgery associated with radiation therapy or che...
  10. [Hepatic transplantation].

    Gastroentérologie Clinique et Biologique 33(8-9):868 (2009) PMID 19556084

    (a) the development of more specific immunosuppressive drugs to prevent rejection, the incidence of which is currently less than 20%: tacrolimus, mycophenolic acid, anti-IL2 receptor antibodies, mTOR inhibitors, (b) a policy of active recruitment of organs together with surgical innovations (split l...